INVITAE CORP. news, videos and press releases - Page 3
For more news please use our advanced search feature.
INVITAE CORP. - More news...
INVITAE CORP. - More news...
- Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND Filing
- Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for all Patients with Cancer
- Invitae and Simons Searchlight Partner to Accelerate Research through Data Sharing
- Invitae to Present at Upcoming Investor Conference
- Invitae Reports $136.6 Million in Revenue in Second Quarter of 2022
- New NCCN Colorectal Cancer Guidelines Recommend Genetic Testing for All Diagnosed Patients
- Invitae to Announce Second Quarter 2022 Financial Results on Tuesday, August 9, 2022
- Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow and Realize Full Potential of Industry-Leading Genetics Testing Platform
- Invitae to Present at Upcoming Investor Conferences
- New Research Demonstrates Genetic Information Can Transform Cancer Care, Guidelines Remain a Barrier to Patient Access
- Invitae Launches Expanded Pharmacogenomics Panel and Specialized Mental Health Panel
- Invitae Reports $123.7 Million in Revenue in First Quarter of 2022 and Extends Cash Runway
- Allelica Collaborates with Invitae to Build Ancestry-Informed Polygenic Risk Score for Breast Cancer
- Invitae to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022
- Invitae Introduces First Comprehensive Genetic Test Suite for Neurodevelopmental Disorders
- Introducing Invitae Digital Health--A Personalized Health Management Platform That Leverages Genomic Insights to Inform Health Decisions for Patients and Clinicians
- Invitae Launches Full Access to its Liquid-Based Personalized Cancer Monitoring Platform to Help Detect Disease Earlier
- Invitae Publishes the 2022 Environmental, Social and Governance Report
- Invitae Reports $460.4 Million in Annual Revenue Driven by 1.17 Million in Billable Volume in 2021
- Invitae Launches its First CE-IVD Cancer Testing Kits In Europe
- Invitae to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022
- Invitae to Present at Upcoming Investor Conferences
- Invitae Supports the Biden Administration's Advancement of the Cancer Moonshot, Enhanced Recommendations on Genetic Testing for Cancer Treatment
- Invitae Reports Preliminary 2021 Revenue of More Than $458 Million and Billable Volume of More Than 1.16 Million
- Invitae to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
- Invitae Reports $114.4 Million in Revenue Driven by 296,000 in Billable Volume in Third Quarter of 2021
- Northwestern University and Invitae Present New Research Highlighting the Importance of Genetic Testing for Cardiovascular Conditions at the American Heart Association Scientific Sessions
- Invitae to Announce Third Quarter 2021 Financial Results on Monday, November 8, 2021
- Invitae, UCL and the Francis Crick Institute Announce New Data From TRACERx Research Collaboration at the 2021 International Society of Liquid Biopsy Congress
- New Study Highlights the Value of Genetic Testing to Guide Clinical Management and Improve Outcomes for Epilepsy Patients
